CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- PositionGross margin is 92.3%, higher than 95% of its Medical Devices peers (median 61.5%)
- FinancialsLow earnings quality
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
909.18MUSDvs all stocks (USD)
Revenue (TTM)
101.96MUSDvs all stocks (USD)
Profit Margin
-64.73%vs Medical Devices peers
52-Week Change
106.00%vs all stocks
Market Capitalization
909.18MUSDvs all stocks (USD)
Enterprise Value
801.83MUSDvs all stocks (USD)
Forward P/E
-14.69xvs Medical Devices peers
Price to Sales (TTM)
8.92xvs Medical Devices peers
Price to Book (MRQ)
7.06xvs Medical Devices peers
Enterprise to Revenue
7.86xvs Medical Devices peers
Enterprise to EBITDA
-11.65xvs Medical Devices peers
Gross Margin
92.32%vs Medical Devices peers
Profit Margin
-64.73%vs Medical Devices peers
Operating Margin
-71.11%vs Medical Devices peers
Return on Assets (TTM)
-23.38%vs Medical Devices peers
Return on Equity (TTM)
-43.93%vs Medical Devices peers
Revenue (TTM)
101.96MUSDvs all stocks (USD)
Revenue per Share (TTM)
2.73USDUpdated Sep 27, 2026Quarterly Revenue Growth
32.50%vs Medical Devices peers
Gross Profit (TTM)
90.64MUSDvs all stocks (USD)
EBITDA (TTM)
-68.80MUSDvs all stocks (USD)
Net Income (TTM)
-66.00MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
32.54%vs Medical Devices peers
Operating Cash Flow (TTM)
-54.03MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-33.05MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Sep 27, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%vs Medical Devices peers
Revenue
89.06MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
10.79MUSDFY2025 · Dec 31, 2025Gross Profit
78.27MUSDFY2025 · Dec 31, 2025Operating Income
-58.40MUSDvs all stocks (USD)
Pre-tax Income
-53.41MUSDFY2025 · Dec 31, 2025Income Tax Expense
0.00USDFY2025 · Dec 31, 2025Net Income
-53.41MUSDFY2025 · Dec 31, 2025EBIT
-51.52MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-50.18MUSDFY2025 · Dec 31, 2025Research & Development
19.14MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
117.53MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
1.89MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-53.41MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-43.47MUSDFY2025 · Dec 31, 2025Free Cash Flow
-44.24MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
40.48MUSDFY2025 · Dec 31, 2025Interest Paid
1.89MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-53.41MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
1.34MUSDFY2025 · Dec 31, 2025Stock-based Compensation
12.22MUSDFY2025 · Dec 31, 2025Other Non-cash Items
314.00KUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-4.89MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
1.75MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-792.00KUSDFY2025 · Dec 31, 2025Capital Expenditures
-767.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-210.81MUSDFY2025 · Dec 31, 2025Sale of Investments
94.20MUSDFY2025 · Dec 31, 2025Other Investing Activity
-755.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-118.14MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Other Financing Charges
-386.00KUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-386.00KUSDFY2025 · Dec 31, 2025Shares Outstanding
38.22MSharesUpdated Sep 27, 2026Float Shares
26.55MSharesUpdated Sep 27, 2026Shares Short
1.82MSharesUpdated Sep 27, 2026Short Ratio
5.59daysvs all stocks
Short % of Shares Outstanding
7.27%vs all stocks
% Held by Insiders
11.84%vs all stocks
% Held by Institutions
87.75%vs all stocks
Total Cash (MRQ)
129.26MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.37USDUpdated Sep 27, 2026Total Debt (MRQ)
21.91MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.1708xvs Medical Devices peers
Current Ratio (MRQ)
9.18xvs Medical Devices peers
Book Value per Share (MRQ)
3.36USDUpdated Sep 27, 2026Total Assets
195.80MUSDvs all stocks (USD)
Total Current Assets
186.72MUSDFY2025 · Dec 31, 2025Total Liabilities
40.47MUSDFY2025 · Dec 31, 2025Total Non-current Assets
9.09MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
21.28MUSDFY2025 · Dec 31, 2025Total Current Liabilities
19.19MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
40.48MUSDFY2025 · Dec 31, 2025Other Short-term Investments
118.78MUSDFY2025 · Dec 31, 2025Accounts Receivable
15.05MUSDFY2025 · Dec 31, 2025Inventory
7.29MUSDFY2025 · Dec 31, 2025Accounts Payable
2.84MUSDFY2025 · Dec 31, 2025Short-term Debt
1.10MUSDFY2025 · Dec 31, 2025Deferred Revenue
101.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
818.00KUSDFY2025 · Dec 31, 2025Long-term Debt
21.17MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
106.00KUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-220.36MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
155.34MUSDvs all stocks (USD)
52-Week Low
10.85USDUpdated Sep 27, 202652-Week High
25.63USDUpdated Sep 27, 202652-Week Change
106.00%vs all stocks
50-Day MA
21.87USDUpdated Sep 27, 2026200-Day MA
20.27USDUpdated Sep 27, 2026Avg 10-Day Volume
423.10KSharesUpdated Sep 27, 2026Avg 30-Day Volume
358.43KSharesUpdated Sep 27, 2026Diluted EPS (TTM)
-1.76USDUpdated Sep 27, 2026Other Income / Expense
6.88MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company financially stable?
Low-Leverage Liquidity Configuration
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 92.3%, higher than 95% of its Medical Devices peers (median 61.5%)Significant
Gross margin: 0.92Industry median: 0.62Industry P95: 0.85Peers compared: 102
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.92Profit Margin: -0.65
Financial Health
Low earnings qualitySignificant
Earnings Quality Score: -0.53
Altman Z-Score 12.52: safe zoneNotable
Altman Z-Score: 12.52
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Companies that share the same coordination system — how they create, deliver, or capture value.
Zhuzhou Qianjin Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
China Isotope & Radiation Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Jade Biosciences Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Rigel Pharmaceuticals, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Alumis Inc.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Cybin Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Hainan Haiyao Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Cloudbreak Pharma Inc.
Tier 1ProductionApproval-Gated PipelineRule
R&G Pharmastudies Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleSenseMaking
Shenzhen YHLO Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Lingda Group Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Chengdu Galaxy Magnets Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration
Suzhou Weizhixiang Food Co., Ltd.
1 interpretationLow-Leverage Liquidity Configuration